B., V. “A REVIEW ON THE DEVELOPMENT OF FAVIPRAVIR AGAINST SARS COV 2 INFECTION”. International Journal of Current Pharmaceutical Research, vol. 14, no. 2, Mar. 2022, pp. 11-14, doi:10.22159/ijcpr.2022v14i2.1957.